Somatostatin Immunostain, Technical Component Only
Use
Somatostatin is a cyclic polypeptide hormone originally isolated from the hypothalamus and is known for its ability to inhibit the release of growth hormone from the pituitary. This test aids in the characterization of pancreatic islet cell tumors and other neuroendocrine tumors by utilizing antibodies to somatostatin, which is produced in the intrinsic nerves of the intestinal wall, endocrine cells of the digestive mucosa, and D cells of pancreatic islets.
Special Instructions
Not provided.
Limitations
The test does not include pathologist interpretation. Stability of paraffin sections varies and is antigen dependent, with best practice suggesting sections to be cut within 6 weeks. Environmental factors can affect the charge and staining of glass slides, potentially leading to inconsistent staining.
FDA ApprovedNew York Approved
Methodology
Immunoassay (IHC)
Biomarkers
Somatostatin
Protein
Result Turnaround Time
1-3 days
Related Documents
For more information, please review the documents below
Specimen
Tissue (FFPE)
Volume
Not provided
Minimum Volume
Not provided
Container
Immunostain Technical Only Envelope
Causes for Rejection
Wet/frozen tissue, cytology smears, nonformalin fixed tissue, nonparaffin embedded tissue, noncharged slides, ProbeOn slides, Snowcoat slides